Cotellic (cobimetinib tablets – Genentech/Roche) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has unresectable, advanced, or metastatic melanoma
• Patient has BRAF V600 mutation-positive disease
• Medication is prescribed in combination with Zelboraf (vemurafenib tablets)

Approval duration

1 year